Table 2.
Univariate and multivariate Cox regression analysis of LINC01446 and survival in patients with GC.
Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
P value | HR | 95% CI | P value | HR | 95% CI | |
OS | ||||||
Age (≤60, >60) | 0.995 | 1.000 | 0.979–1.022 | 0.960 | 0.999 | 0.977–1.022 |
Gender (male, female) | 0.125 | 0.636 | 0.357–1.134 | 0.441 | 0.784 | 0.421–1.457 |
Lauren classification | 0.154 | 0.720 | 0.459–1.131 | 0.021 | 0.576 | 0.361–0.919 |
TNM stage (I/II, III/IV) | <0.001 | 2.610 | 1.843–3.696 | <0.001 | 2.547 | 1.775–3.655 |
Tumor invasion depth (T1/T2, T3/T4) | 0.064 | 1.283 | 0.985–1.671 | 0.440 | 0.895 | 0.677–1.185 |
Lymph node metastasis (N0, N1) | 0.003 | 1.418 | 1.125–1.786 | 0.760 | 0.952 | 0.693–1.308 |
Distant metastasis (yes, no) | <0.001 | 4.400 | 2.432–7.959 | 0.991 | 1.007 | 0.297–3.413 |
LINC01446 expression | <0.001 | 5.730 | 3.106–10.568 | <0.001 | 4.446 | 2.409–8.206 |
DFS | ||||||
Age (≤60, >60) | 0.993 | 1.000 | 0.979–1.022 | 0.946 | 1.001 | 0.978–1.024 |
Gender (male, female) | 0.122 | 0.626 | 0.351–1.116 | 0.371 | 0.752 | 0.403–1.403 |
Lauren classification | 0.153 | 0.721 | 0.460–1.028 | 0.020 | 0.576 | 0.362–0.917 |
TNM stage (I/II, III/IV) | <0.001 | 2.594 | 1.834–3.670 | <0.001 | 2.566 | 1.786–3.687 |
Tumor invasion depth (T1/T2, T3/T4) | 0.069 | 1.275 | 0.981–1.657 | 0.371 | 0.881 | 0.667–1.163 |
Lymph node metastasis (N0, N1) | 0.002 | 1.433 | 1.137–1.806 | 0.983 | 0.996 | 0.698–1.421 |
Distant metastasis (yes, no) | <0.001 | 4.346 | 2.405–7.851 | 0.845 | 1.113 | 0.379–3.267 |
LINC01446 expression | <0.001 | 6.126 | 3.324–11.289 | <0.001 | 4.928 | 2.671–9.090 |
HR > 1, risk for death increased; HR < 1, risk for death reduced. Significant P values are shown in bold font.
OS overall survival, DFS disease-free survival, TNM tumor node metastasis, HR hazard ratio, CI confidence interval.